These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 31015582)

  • 1. Obesity, kidney dysfunction and hypertension: mechanistic links.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Nat Rev Nephrol; 2019 Jun; 15(6):367-385. PubMed ID: 31015582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity, kidney dysfunction, and inflammation: interactions in hypertension.
    Hall JE; Mouton AJ; da Silva AA; Omoto ACM; Wang Z; Li X; do Carmo JM
    Cardiovasc Res; 2021 Jul; 117(8):1859-1876. PubMed ID: 33258945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central proopiomelanocortin but not neuropeptide Y mediates sympathoexcitation and hypertension in fat fed conscious rabbits.
    Barzel B; Lim K; Davern PJ; Burke SL; Armitage JA; Head GA
    J Hypertens; 2016 Mar; 34(3):464-73; discussion 473. PubMed ID: 26820476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins.
    Hall JE; da Silva AA; do Carmo JM; Dubinion J; Hamza S; Munusamy S; Smith G; Stec DE
    J Biol Chem; 2010 Jun; 285(23):17271-6. PubMed ID: 20348094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Aldosterone in Obesity-Related Hypertension.
    Kawarazaki W; Fujita T
    Am J Hypertens; 2016 Apr; 29(4):415-23. PubMed ID: 26927805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
    Kawarazaki W; Fujita T
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and insulin resistance in resistant hypertension: implications for the kidney.
    Rao A; Pandya V; Whaley-Connell A
    Adv Chronic Kidney Dis; 2015 May; 22(3):211-7. PubMed ID: 25908470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone Contributes to Sympathoexcitation in Renovascular Hypertension.
    Lincevicius GS; Shimoura CG; Nishi EE; Perry JC; Casarini DE; Gomes GN; Bergamaschi CT; Campos RR
    Am J Hypertens; 2015 Sep; 28(9):1083-90. PubMed ID: 25628418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of obesity hypertension.
    Hall JE
    Curr Hypertens Rep; 2000 Apr; 2(2):139-47. PubMed ID: 10981140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the sympathetic nervous system in obesity-related hypertension.
    da Silva AA; do Carmo J; Dubinion J; Hall JE
    Curr Hypertens Rep; 2009 Jun; 11(3):206-11. PubMed ID: 19442330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin-Aldosterone-Neprilysin Axis: Identification of Its Distinctive Role in the Pathogenesis of the Three Phenotypes of Heart Failure in People With Obesity.
    Packer M
    Circulation; 2018 Apr; 137(15):1614-1631. PubMed ID: 29632154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sympathetic hyperactivity in hypertension].
    Takahashi H
    Nihon Rinsho; 2008 Aug; 66(8):1495-502. PubMed ID: 18700548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin, Obesity, and Hypertension: A Review of Pathogenetic Mechanisms.
    Lu SC; Akanji AO
    Metab Syndr Relat Disord; 2020 Nov; 18(9):399-405. PubMed ID: 32876506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the obesity epidemic on hypertension and renal disease.
    Hall JE; Jones DW; Kuo JJ; da Silva A; Tallam LS; Liu J
    Curr Hypertens Rep; 2003 Oct; 5(5):386-92. PubMed ID: 12948431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome.
    Cabandugama PK; Gardner MJ; Sowers JR
    Med Clin North Am; 2017 Jan; 101(1):129-137. PubMed ID: 27884224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salt-Sensitive Hypertension and the Kidney.
    Nishimoto M; Griffin KA; Wynne BM; Fujita T
    Hypertension; 2024 Jun; 81(6):1206-1217. PubMed ID: 38545804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of leptin and central nervous system melanocortins in obesity hypertension.
    da Silva AA; do Carmo JM; Hall JE
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):135-40. PubMed ID: 23299052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is obesity a major cause of chronic kidney disease?
    Hall JE; Henegar JR; Dwyer TM; Liu J; Da Silva AA; Kuo JJ; Tallam L
    Adv Ren Replace Ther; 2004 Jan; 11(1):41-54. PubMed ID: 14730537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, hypertension, and chronic kidney disease.
    Hall ME; do Carmo JM; da Silva AA; Juncos LA; Wang Z; Hall JE
    Int J Nephrol Renovasc Dis; 2014; 7():75-88. PubMed ID: 24600241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.